financetom
Business
financetom
/
Business
/
Iron Mountain Q3 profit beats estimates on higher storage rental and service revenue
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Iron Mountain Q3 profit beats estimates on higher storage rental and service revenue
Nov 5, 2025 4:17 AM

Overview

* Iron Mountain Q3 revenue rises 12.6% yr/yr, meeting analyst expectations

* Adjusted EPS for Q3 beats analyst expectations, reflecting strong performance

* Company increases quarterly dividend by 10%, driven by AFFO growth

Outlook

* Iron Mountain reiterates full-year 2025 guidance, with Q4 revenue expected to rise ~14%

* Company expects Q4 2025 adjusted EBITDA to increase ~14%

Result Drivers

* GROWTH BUSINESSES - Data center, digital, and ALM businesses collectively grew over 30% year-over-year, driving revenue growth

* REVENUE INCREASE - Record revenue of $1.8 bln, driven by a 9.5% increase in storage rental revenue and a 15.3% increase in service revenue

* ADJUSTED EBITDA GROWTH - Record Adjusted EBITDA of $660 mln, driven by increased revenue and improved operating leverage

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Meet $1.75 $1.75

Revenue bln bln (8

Analysts

)

Q3 Beat $0.54 $0.53 (6

Adjusted Analysts

EPS )

Q3 EPS $0.28

Q3 Net $86 mln

Income

Q3 Beat $660 mln $639.80

Adjusted mln (7

EBITDA Analysts

)

Q3 37.60%

Adjusted

EBITDA

Margin

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the specialized reits peer group is "buy"

* Wall Street's median 12-month price target for Iron Mountain Inc ( IRM ) is $122.00, about 15.3% above its November 4 closing price of $103.32

* The stock recently traded at 45 times the next 12-month earnings vs. a P/E of 45 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MVB Financial's Q3 net income surges driven by loan growth
MVB Financial's Q3 net income surges driven by loan growth
Oct 29, 2025
Overview * MVB Financial ( MVBF ) Q3 net income at $17.1 mln, reflecting strategic moves * Company completed $10 mln share repurchase program, boosting shareholder value * Sale of Victor Technologies generated $34.1 mln pre-tax gain, enhancing strategic flexibility Outlook * Company expects securities repositioning to add $0.30 to $0.35 to annualized EPS * Company sees solid loan pipeline...
Natural gas producer Antero posts Q3 adjusted net income 
Natural gas producer Antero posts Q3 adjusted net income 
Oct 29, 2025
Overview * Antero Q3 adjusted net income of $48.2 mln, compared to loss of $51.8 mln yr ago * Adjusted EBITDAX increased 70% yr/yr, reflecting operational improvements * Company completed $260 mln strategic acquisitions in core Marcellus footprint Outlook * Antero expects Q4 2025 production to increase to 3.5-3.525 Bcfe/d * Full-year 2025 production expected at high end of 3.4-3.45...
Antero Midstream beats Q3 revenue and adjusted EBITDA estimates
Antero Midstream beats Q3 revenue and adjusted EBITDA estimates
Oct 29, 2025
Overview * Antero Midstream ( AM ) Q3 revenue and adjusted EBITDA beat analyst expectations * Adjusted net income for Q3 beats estimates, rising 17% year-over-year * Company repurchased 2.3 mln shares for $41 mln, reducing leverage to 2.7x Outlook * Company plans additional well connections and fresh water delivery for 2026 * Company refinanced nearest-term debt maturity to 2033...
US FDA places clinical hold on Intellia's two gene-editing treatment trials
US FDA places clinical hold on Intellia's two gene-editing treatment trials
Oct 29, 2025
Oct 29 (Reuters) - Intellia Therapeutics ( NTLA ) said on Wednesday that the U.S. Food and Drug Administration has placed a clinical hold on its two late-stage trials testing an experimental gene-editing therapy for a rare disease that can damage the heart and nerves. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved